Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function
Biomedical Chromatography · 2026-06 · 40 (6)
DOI: 10.1002/bmc.70455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 27.04.2026. Verfasst von Ze-Chao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Drugs, Chinese Herbal, Metabolome, Proteome. Die Arbeit nennt 29 Literaturangaben. Gefördert von: 2025 Youth Research Fund Project of Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Guangxi Natural Science Foundation, Natural Science Foundation of Guangxi Province.
Abstract (Originalsprache)
To investigate the molecular mechanism of Qianlong Shutong formula (QLSTF) in treating benign prostatic hyperplasia (BPH) through the regulation of metabolism and protein function. An integrated metabolomics and proteomics analysis was conducted using a BPH animal model. The animals were divided into a control group, a model group, and a QLSTF intervention group. Following drug intervention, metabolite extraction and protein sample processing were performed. Metabolomics results indicated the presence of metabolic disorders in the model group, which were significantly ameliorated by QLSTF through the regulation of relevant metabolic pathways. Quantitative proteomic analysis identified multiple differentially expressed proteins. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Clusters of Orthologous Groups (COG) enrichment analyses revealed that these proteins are involved in biological processes such as cell proliferation, apoptosis, and inflammatory responses. Correlation analysis demonstrated a synergistic relationship between metabolite levels and protein expression. Integrated analyses revealed metabolic disorders and differential protein expression, providing multiomics evidence for QLSTF's mechanism. QLSTF alleviates BPH by modulating metabolic pathways and protein networks, providing a molecular basis for TCM in BPH treatment and suggesting future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China.
ORCID-Profile: Min Zhu
Förderung
- 2025 Youth Research Fund Project of Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine
- Guangxi Natural Science Foundation
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Zhang, Z. C., Ye, X. J., Shang, C. J., Chen, Y., Guo, L., Li, Y. W., Zhu, M., Tang, B. T., & Liang, T. S. (2026). Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function. Biomedical Chromatography, 40(6). https://doi.org/10.1002/bmc.70455
Vancouver
Zhang ZC, Ye XJ, Shang CJ, Chen Y, Guo L, Li YW, et al. Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function. Biomedical Chromatography. 2026;40(6). doi:10.1002/bmc.70455
BibTeX
@article{Zhang2026,
author = {Zhang, Ze-Chao and Ye, Xue-Jin and Shang, Chang-Jie and Chen, Yu and Guo, Lin and Li, Yi-Wen and Zhu, Min and Tang, Bo-Tao and Liang, Tai-Sheng},
title = {Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {6},
doi = {10.1002/bmc.70455}
}
EUVIMED